618 related articles for article (PubMed ID: 20120980)
1. Esophageal cancer subtypes and survival rates at the VA Caribbean Healthcare System: a 10-year experience.
González Ortiz DI; Toro DH
Bol Asoc Med P R; 2009; 101(3):14-7. PubMed ID: 20120980
[TBL] [Abstract][Full Text] [Related]
2. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.
Meredith KL; Weber JM; Turaga KK; Siegel EM; McLoughlin J; Hoffe S; Marcovalerio M; Shah N; Kelley S; Karl R
Ann Surg Oncol; 2010 Apr; 17(4):1159-67. PubMed ID: 20140529
[TBL] [Abstract][Full Text] [Related]
3. Three decades of treatment of esophageal squamous carcinoma at the Massachusetts General Hospital.
Katlic MR; Wilkins EW; Grillo HC
J Thorac Cardiovasc Surg; 1990 May; 99(5):929-38. PubMed ID: 2329832
[TBL] [Abstract][Full Text] [Related]
4. Changing pattern of esophageal cancer incidence in New Mexico.
Vega KJ; Jamal MM
Am J Gastroenterol; 2000 Sep; 95(9):2352-6. PubMed ID: 11007241
[TBL] [Abstract][Full Text] [Related]
5. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
Chang DT; Chapman C; Shen J; Su Z; Koong AC
Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
[TBL] [Abstract][Full Text] [Related]
6. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy.
Wolfe WG; Vaughn AL; Seigler HF; Hathorn JW; Leopold KA; Duhaylongsod FG
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):749-55; discussion 755-6. PubMed ID: 8469009
[TBL] [Abstract][Full Text] [Related]
7. Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus.
Adham M; Baulieux J; Mornex F; de La Roche de Bransat E; Ducerf C; Souquet JC; Gerard JP
Cancer; 2000 Sep; 89(5):946-54. PubMed ID: 10964323
[TBL] [Abstract][Full Text] [Related]
8. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
9. Optimal treatment for localized esophageal cancer still uncertain.
Lord RV
Am J Gastroenterol; 2000 Jan; 95(1):305-7. PubMed ID: 10638607
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma of the esophagus in Tamil Nadu (South India): 16-year trends from a tertiary center.
Cherian JV; Sivaraman R; Muthusamy AK; Jayanthi V
J Gastrointestin Liver Dis; 2007 Sep; 16(3):245-9. PubMed ID: 17925916
[TBL] [Abstract][Full Text] [Related]
11. Recent trends in the epidemiology of esophageal cancer. Comparison of epidermoid- and adenocarcinomas.
Moyana TN; Janoski M
Ann Clin Lab Sci; 1996; 26(6):480-6. PubMed ID: 8908317
[TBL] [Abstract][Full Text] [Related]
12. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma.
Vaughan TL; Davis S; Kristal A; Thomas DB
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):85-92. PubMed ID: 7742727
[TBL] [Abstract][Full Text] [Related]
13. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
[TBL] [Abstract][Full Text] [Related]
14. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
[TBL] [Abstract][Full Text] [Related]
16. [Incidence and pathologic distribution of esophageal cancers at the gastro-esophageal junction between 1993-2003].
Lakatos PL; Lakatos L; Fuszek P; Lukovich P; Kupcsulik P; Halbász J; Schaff Z; Papp J
Orv Hetil; 2005 Feb; 146(9):411-6. PubMed ID: 15830608
[TBL] [Abstract][Full Text] [Related]
17. Retrospective review of patients with locally advanced esophageal cancer treated at the University of Pittsburgh.
Defoe SG; Pennathur A; Flickinger JC; Heron DE; Gibson MK; Luketich JD; Greenberger JS
Am J Clin Oncol; 2011 Dec; 34(6):587-92. PubMed ID: 22101387
[TBL] [Abstract][Full Text] [Related]
18. Preoperative chemotherapy and radiotherapy for esophageal carcinoma.
Naunheim KS; Petruska P; Roy TS; Andrus CH; Johnson FE; Schlueter JM; Baue AE
J Thorac Cardiovasc Surg; 1992 May; 103(5):887-93; discussion 893-5. PubMed ID: 1569771
[TBL] [Abstract][Full Text] [Related]
19. Response to definitive chemoradiotherapy and survival in patients with an oesophageal adenocarcinoma versus squamous cell carcinoma: a matched-pair analysis.
Tougeron D; Di Fiore F; Hamidou H; Rigal O; Paillot B; Michel P
Oncology; 2007; 73(5-6):328-34. PubMed ID: 18497505
[TBL] [Abstract][Full Text] [Related]
20. The lack of association between adenocarcinoma of the esophagus and gastric surgery: a retrospective study.
Birgisson S; Rice TW; Easley KA; Richter JE
Am J Gastroenterol; 1997 Feb; 92(2):216-21. PubMed ID: 9040194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
